 | • レポートコード：QYR2104Z0793 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、新型コロナウイルス感染症におけるバイオ医薬品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（中和抗体、抗炎症薬）、用途別市場規模（新型コロナウイルス感染症、インフルエンザ、マラリア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・新型コロナウイルス感染症におけるバイオ医薬品の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症におけるバイオ医薬品の種類別市場規模（中和抗体、抗炎症薬） ・新型コロナウイルス感染症におけるバイオ医薬品の用途別市場規模（新型コロナウイルス感染症、インフルエンザ、マラリア、その他） ・新型コロナウイルス感染症におけるバイオ医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症におけるバイオ医薬品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症におけるバイオ医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症におけるバイオ医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症におけるバイオ医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Sanofi、Novartis、Merck、Bayer、Shutaishen、Biogen、Regeneron Pharmaceuticals、Vir Biotech、Junshi Biosciences、Anke Biotechnology、OncoImmune） ・結論 |
According to China’s clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
Market Analysis and Insights: Global Biologic Medication in COVID-19 Market
The global Biologic Medication in COVID-19 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Medication in COVID-19 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Medication in COVID-19 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Medication in COVID-19 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Medication in COVID-19 market.
Global Biologic Medication in COVID-19 Scope and Market Size
Biologic Medication in COVID-19 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Medication in COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Neutralizing Antibodies
Anti-inflammatory Drugs
Segment by Application
COVID-19
Influenza
Malaria
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Sanofi
Novartis
Merck
Bayer
Shutaishen
Biogen
Regeneron Pharmaceuticals
Vir Biotech
Junshi Biosciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Medication in COVID-19 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neutralizing Antibodies
1.2.3 Anti-inflammatory Drugs
1.3 Market by Application
1.3.1 Global Biologic Medication in COVID-19 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 COVID-19
1.3.3 Influenza
1.3.4 Malaria
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologic Medication in COVID-19 Market Perspective (2016-2027)
2.2 Biologic Medication in COVID-19 Growth Trends by Regions
2.2.1 Biologic Medication in COVID-19 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologic Medication in COVID-19 Historic Market Share by Regions (2016-2021)
2.2.3 Biologic Medication in COVID-19 Forecasted Market Size by Regions (2022-2027)
2.3 Biologic Medication in COVID-19 Industry Dynamic
2.3.1 Biologic Medication in COVID-19 Market Trends
2.3.2 Biologic Medication in COVID-19 Market Drivers
2.3.3 Biologic Medication in COVID-19 Market Challenges
2.3.4 Biologic Medication in COVID-19 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Medication in COVID-19 Players by Revenue
3.1.1 Global Top Biologic Medication in COVID-19 Players by Revenue (2016-2021)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2016-2021)
3.2 Global Biologic Medication in COVID-19 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologic Medication in COVID-19 Revenue
3.4 Global Biologic Medication in COVID-19 Market Concentration Ratio
3.4.1 Global Biologic Medication in COVID-19 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Medication in COVID-19 Revenue in 2020
3.5 Biologic Medication in COVID-19 Key Players Head office and Area Served
3.6 Key Players Biologic Medication in COVID-19 Product Solution and Service
3.7 Date of Enter into Biologic Medication in COVID-19 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medication in COVID-19 Breakdown Data by Type
4.1 Global Biologic Medication in COVID-19 Historic Market Size by Type (2016-2021)
4.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2022-2027)
5 Biologic Medication in COVID-19 Breakdown Data by Application
5.1 Global Biologic Medication in COVID-19 Historic Market Size by Application (2016-2021)
5.2 Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biologic Medication in COVID-19 Market Size (2016-2027)
6.2 North America Biologic Medication in COVID-19 Market Size by Type
6.2.1 North America Biologic Medication in COVID-19 Market Size by Type (2016-2021)
6.2.2 North America Biologic Medication in COVID-19 Market Size by Type (2022-2027)
6.2.3 North America Biologic Medication in COVID-19 Market Size by Type (2016-2027)
6.3 North America Biologic Medication in COVID-19 Market Size by Application
6.3.1 North America Biologic Medication in COVID-19 Market Size by Application (2016-2021)
6.3.2 North America Biologic Medication in COVID-19 Market Size by Application (2022-2027)
6.3.3 North America Biologic Medication in COVID-19 Market Size by Application (2016-2027)
6.4 North America Biologic Medication in COVID-19 Market Size by Country
6.4.1 North America Biologic Medication in COVID-19 Market Size by Country (2016-2021)
6.4.2 North America Biologic Medication in COVID-19 Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Biologic Medication in COVID-19 Market Size (2016-2027)
7.2 Europe Biologic Medication in COVID-19 Market Size by Type
7.2.1 Europe Biologic Medication in COVID-19 Market Size by Type (2016-2021)
7.2.2 Europe Biologic Medication in COVID-19 Market Size by Type (2022-2027)
7.2.3 Europe Biologic Medication in COVID-19 Market Size by Type (2016-2027)
7.3 Europe Biologic Medication in COVID-19 Market Size by Application
7.3.1 Europe Biologic Medication in COVID-19 Market Size by Application (2016-2021)
7.3.2 Europe Biologic Medication in COVID-19 Market Size by Application (2022-2027)
7.3.3 Europe Biologic Medication in COVID-19 Market Size by Application (2016-2027)
7.4 Europe Biologic Medication in COVID-19 Market Size by Country
7.4.1 Europe Biologic Medication in COVID-19 Market Size by Country (2016-2021)
7.4.2 Europe Biologic Medication in COVID-19 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biologic Medication in COVID-19 Market Size (2016-2027)
8.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type
8.2.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application
8.3.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region
8.4.1 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologic Medication in COVID-19 Market Size (2016-2027)
9.2 Latin America Biologic Medication in COVID-19 Market Size by Type
9.2.1 Latin America Biologic Medication in COVID-19 Market Size by Type (2016-2021)
9.2.2 Latin America Biologic Medication in COVID-19 Market Size by Type (2022-2027)
9.2.3 Latin America Biologic Medication in COVID-19 Market Size by Type (2016-2027)
9.3 Latin America Biologic Medication in COVID-19 Market Size by Application
9.3.1 Latin America Biologic Medication in COVID-19 Market Size by Application (2016-2021)
9.3.2 Latin America Biologic Medication in COVID-19 Market Size by Application (2022-2027)
9.3.3 Latin America Biologic Medication in COVID-19 Market Size by Application (2016-2027)
9.4 Latin America Biologic Medication in COVID-19 Market Size by Country
9.4.1 Latin America Biologic Medication in COVID-19 Market Size by Country (2016-2021)
9.4.2 Latin America Biologic Medication in COVID-19 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Medication in COVID-19 Market Size (2016-2027)
10.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type
10.2.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application
10.3.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country
10.4.1 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Biologic Medication in COVID-19 Introduction
11.1.4 Roche Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Biologic Medication in COVID-19 Introduction
11.2.4 Sanofi Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Biologic Medication in COVID-19 Introduction
11.3.4 Novartis Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Biologic Medication in COVID-19 Introduction
11.4.4 Merck Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Biologic Medication in COVID-19 Introduction
11.5.4 Bayer Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Shutaishen
11.6.1 Shutaishen Company Details
11.6.2 Shutaishen Business Overview
11.6.3 Shutaishen Biologic Medication in COVID-19 Introduction
11.6.4 Shutaishen Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.6.5 Shutaishen Recent Development
11.7 Biogen
11.7.1 Biogen Company Details
11.7.2 Biogen Business Overview
11.7.3 Biogen Biologic Medication in COVID-19 Introduction
11.7.4 Biogen Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.7.5 Biogen Recent Development
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Details
11.8.2 Regeneron Pharmaceuticals Business Overview
11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Introduction
11.8.4 Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.8.5 Regeneron Pharmaceuticals Recent Development
11.9 Vir Biotech
11.9.1 Vir Biotech Company Details
11.9.2 Vir Biotech Business Overview
11.9.3 Vir Biotech Biologic Medication in COVID-19 Introduction
11.9.4 Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.9.5 Vir Biotech Recent Development
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Details
11.10.2 Junshi Biosciences Business Overview
11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Introduction
11.10.4 Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.10.5 Junshi Biosciences Recent Development
11.11 Anke Biotechnology
11.11.1 Anke Biotechnology Company Details
11.11.2 Anke Biotechnology Business Overview
11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Introduction
11.11.4 Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.11.5 Anke Biotechnology Recent Development
11.12 OncoImmune
11.12.1 OncoImmune Company Details
11.12.2 OncoImmune Business Overview
11.12.3 OncoImmune Biologic Medication in COVID-19 Introduction
11.12.4 OncoImmune Revenue in Biologic Medication in COVID-19 Business (2016-2021)
11.12.5 OncoImmune Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biologic Medication in COVID-19 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neutralizing Antibodies
Table 3. Key Players of Anti-inflammatory Drugs
Table 4. Global Biologic Medication in COVID-19 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biologic Medication in COVID-19 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biologic Medication in COVID-19 Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biologic Medication in COVID-19 Market Share by Regions (2016-2021)
Table 8. Global Biologic Medication in COVID-19 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biologic Medication in COVID-19 Market Share by Regions (2022-2027)
Table 10. Biologic Medication in COVID-19 Market Trends
Table 11. Biologic Medication in COVID-19 Market Drivers
Table 12. Biologic Medication in COVID-19 Market Challenges
Table 13. Biologic Medication in COVID-19 Market Restraints
Table 14. Global Biologic Medication in COVID-19 Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biologic Medication in COVID-19 Market Share by Players (2016-2021)
Table 16. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Medication in COVID-19 as of 2020)
Table 17. Ranking of Global Top Biologic Medication in COVID-19 Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biologic Medication in COVID-19 Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biologic Medication in COVID-19 Product Solution and Service
Table 21. Date of Enter into Biologic Medication in COVID-19 Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biologic Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2016-2021)
Table 25. Global Biologic Medication in COVID-19 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biologic Medication in COVID-19 Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biologic Medication in COVID-19 Revenue Market Share by Application (2016-2021)
Table 29. Global Biologic Medication in COVID-19 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biologic Medication in COVID-19 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biologic Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biologic Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biologic Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biologic Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biologic Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biologic Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biologic Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biologic Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biologic Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biologic Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biologic Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biologic Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biologic Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biologic Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biologic Medication in COVID-19 Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biologic Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biologic Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biologic Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biologic Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biologic Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biologic Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biologic Medication in COVID-19 Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Biologic Medication in COVID-19 Product
Table 64. Roche Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Biologic Medication in COVID-19 Product
Table 69. Sanofi Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Biologic Medication in COVID-19 Product
Table 74. Novartis Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Biologic Medication in COVID-19 Product
Table 79. Merck Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Bayer Company Details
Table 82. Bayer Business Overview
Table 83. Bayer Biologic Medication in COVID-19 Product
Table 84. Bayer Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 85. Bayer Recent Development
Table 86. Shutaishen Company Details
Table 87. Shutaishen Business Overview
Table 88. Shutaishen Biologic Medication in COVID-19 Product
Table 89. Shutaishen Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 90. Shutaishen Recent Development
Table 91. Biogen Company Details
Table 92. Biogen Business Overview
Table 93. Biogen Biologic Medication in COVID-19 Product
Table 94. Biogen Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 95. Biogen Recent Development
Table 96. Regeneron Pharmaceuticals Company Details
Table 97. Regeneron Pharmaceuticals Business Overview
Table 98. Regeneron Pharmaceuticals Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 99. Regeneron Pharmaceuticals Recent Development
Table 100. Vir Biotech Company Details
Table 101. Vir Biotech Business Overview
Table 102. Vir Biotech Biologic Medication in COVID-19 Product
Table 103. Vir Biotech Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 104. Vir Biotech Recent Development
Table 105. Junshi Biosciences Company Details
Table 106. Junshi Biosciences Business Overview
Table 107. Junshi Biosciences Biologic Medication in COVID-19 Product
Table 108. Junshi Biosciences Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 109. Junshi Biosciences Recent Development
Table 110. Anke Biotechnology Company Details
Table 111. Anke Biotechnology Business Overview
Table 112. Anke Biotechnology Biologic Medication in COVID-19 Product
Table 113. Anke Biotechnology Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 114. Anke Biotechnology Recent Development
Table 115. OncoImmune Company Details
Table 116. OncoImmune Business Overview
Table 117. OncoImmune Biologic Medication in COVID-19 Product
Table 118. OncoImmune Revenue in Biologic Medication in COVID-19 Business (2016-2021) & (US$ Million)
Table 119. OncoImmune Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Medication in COVID-19 Market Share by Type: 2020 VS 2027
Figure 2. Neutralizing Antibodies Features
Figure 3. Anti-inflammatory Drugs Features
Figure 4. Global Biologic Medication in COVID-19 Market Share by Application: 2020 VS 2027
Figure 5. COVID-19 Case Studies
Figure 6. Influenza Case Studies
Figure 7. Malaria Case Studies
Figure 8. Others Case Studies
Figure 9. Biologic Medication in COVID-19 Report Years Considered
Figure 10. Global Biologic Medication in COVID-19 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biologic Medication in COVID-19 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biologic Medication in COVID-19 Market Share by Regions: 2020 VS 2027
Figure 13. Global Biologic Medication in COVID-19 Market Share by Regions (2022-2027)
Figure 14. Global Biologic Medication in COVID-19 Market Share by Players in 2020
Figure 15. Global Top Biologic Medication in COVID-19 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Medication in COVID-19 as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biologic Medication in COVID-19 Revenue in 2020
Figure 17. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2016-2021)
Figure 18. Global Biologic Medication in COVID-19 Revenue Market Share by Type (2022-2027)
Figure 19. North America Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biologic Medication in COVID-19 Market Share by Type (2016-2027)
Figure 21. North America Biologic Medication in COVID-19 Market Share by Application (2016-2027)
Figure 22. North America Biologic Medication in COVID-19 Market Share by Country (2016-2027)
Figure 23. United States Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biologic Medication in COVID-19 Market Share by Type (2016-2027)
Figure 27. Europe Biologic Medication in COVID-19 Market Share by Application (2016-2027)
Figure 28. Europe Biologic Medication in COVID-19 Market Share by Country (2016-2027)
Figure 29. Germany Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biologic Medication in COVID-19 Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biologic Medication in COVID-19 Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biologic Medication in COVID-19 Market Share by Region (2016-2027)
Figure 39. China Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biologic Medication in COVID-19 Market Share by Type (2016-2027)
Figure 47. Latin America Biologic Medication in COVID-19 Market Share by Application (2016-2027)
Figure 48. Latin America Biologic Medication in COVID-19 Market Share by Country (2016-2027)
Figure 49. Mexico Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biologic Medication in COVID-19 Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biologic Medication in COVID-19 Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biologic Medication in COVID-19 Market Share by Country (2016-2027)
Figure 55. Turkey Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biologic Medication in COVID-19 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 63. Shutaishen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 64. Biogen Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 65. Regeneron Pharmaceuticals Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 66. Vir Biotech Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 67. Junshi Biosciences Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 68. Anke Biotechnology Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 69. OncoImmune Revenue Growth Rate in Biologic Medication in COVID-19 Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed